HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LFA-3 (CD58) mediates T-lymphocyte adhesion in chronic inflammatory infiltrates.

Abstract
Previous studies have suggested that LFA-3 has an important role in a number of chronic inflammatory pathologies, although an active role for LFA-3 within in vivo inflammatory reactions has not previously been directly observed in humans. To assess the importance of LFA-3 in this process, this study used an adaptation of the Stamper-Woodruff lymphocyte adhesion assay to measure the binding of exogenous activated lymphocytes to the T-cell-dominated chronic inflammatory infiltrate of oral lichen planus. Antibody blockade experiments showed that anti-LFA-3 monoclonal antibody reduced lymphocyte adhesion by approximately 29%, while anti-ICAM-1 produced a reduction of 26%. These results thus suggest that both LFA-3 and ICAM-1 are likely to mediate cell-cell interactions within lesional tissues in vivo. Moreover, these findings are also the first to directly demonstrate that LFA-3-mediated adhesion, like that of ICAM-1, is functionally important in the molecular pathology of inflammatory mucosal disease.
AuthorsA C Kirby, P Cahen, S R Porter, I Olsen
JournalScandinavian journal of immunology (Scand J Immunol) Vol. 50 Issue 5 Pg. 469-74 (Nov 1999) ISSN: 0300-9475 [Print] England
PMID10564548 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • CD58 Antigens
Topics
  • Adult
  • Antibodies, Monoclonal
  • CD58 Antigens (metabolism)
  • Case-Control Studies
  • Cell Adhesion (immunology)
  • Female
  • Humans
  • In Vitro Techniques
  • Inflammation (immunology, pathology)
  • Lichen Planus, Oral (immunology, pathology)
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • T-Lymphocytes (immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: